BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25996601)

  • 21. Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer.
    de Vos tot Nederveen Cappel WH; Meulenbeld HJ; Kleibeuker JH; Nagengast FM; Menko FH; Griffioen G; Cats A; Morreau H; Gelderblom H; Vasen HF
    Int J Cancer; 2004 Apr; 109(3):468-71. PubMed ID: 14961589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
    Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
    JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated microsatellite alterations at selected tetranucleotides in early-stage colorectal cancers with and without high-frequency microsatellite instability: same, same but different?
    Watson MM; Lea D; Rewcastle E; Hagland HR; Søreide K
    Cancer Med; 2016 Jul; 5(7):1580-7. PubMed ID: 27061136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer.
    Haugen AC; Goel A; Yamada K; Marra G; Nguyen TP; Nagasaka T; Kanazawa S; Koike J; Kikuchi Y; Zhong X; Arita M; Shibuya K; Oshimura M; Hemmi H; Boland CR; Koi M
    Cancer Res; 2008 Oct; 68(20):8465-72. PubMed ID: 18922920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer.
    Ohrling K; Edler D; Hallström M; Ragnhammar P
    Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.
    Bendardaf R; Lamlum H; Ristamäki R; Korkeila E; Syrjänen K; Pyrhönen S
    Acta Oncol; 2008; 47(6):1046-53. PubMed ID: 17943475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 6 alters localization of hMSH3, leading to DNA mismatch repair defects in colorectal cancer cells.
    Tseng-Rogenski SS; Hamaya Y; Choi DY; Carethers JM
    Gastroenterology; 2015 Mar; 148(3):579-89. PubMed ID: 25461668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microsatellite instability at tetranucleotide repeats in sporadic colorectal cancer in Japan.
    Yamada K; Kanazawa S; Koike J; Sugiyama H; Xu C; Funahashi K; Boland CR; Koi M; Hemmi H
    Oncol Rep; 2010 Feb; 23(2):551-61. PubMed ID: 20043121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.
    Song K; Guo Y; Wang X; Cai H; Zheng W; Li N; Song X; Ao L; Guo Z; Zhao W
    FASEB J; 2019 Jan; 33(1):151-162. PubMed ID: 29957060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy.
    Tang R; Wang JY; Fan CW; Tsao KC; Chen HH; Wu CM; Chen JS; Changchien CR; Hsieh LL
    Cancer Lett; 2004 Jul; 210(1):101-9. PubMed ID: 15172127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation-Associated Microsatellite Alterations Caused by MSH3 Dysfunction Are Prevalent in Ulcerative Colitis and Increase With Neoplastic Advancement.
    Munakata K; Koi M; Kitajima T; Tseng-Rogenski S; Uemura M; Matsuno H; Kawai K; Sekido Y; Mizushima T; Toiyama Y; Yamada T; Mano M; Mita E; Kusunoki M; Mori M; Carethers JM
    Clin Transl Gastroenterol; 2019 Dec; 10(12):e00105. PubMed ID: 31789935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle.
    Tejpar S; Saridaki Z; Delorenzi M; Bosman F; Roth AD
    J Natl Cancer Inst; 2011 Jun; 103(11):841-4. PubMed ID: 21597023
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer.
    Carethers JM; Smith EJ; Behling CA; Nguyen L; Tajima A; Doctolero RT; Cabrera BL; Goel A; Arnold CA; Miyai K; Boland CR
    Gastroenterology; 2004 Feb; 126(2):394-401. PubMed ID: 14762775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsatellite instability and colorectal cancer prognosis.
    Benatti P; Gafà R; Barana D; Marino M; Scarselli A; Pedroni M; Maestri I; Guerzoni L; Roncucci L; Menigatti M; Roncari B; Maffei S; Rossi G; Ponti G; Santini A; Losi L; Di Gregorio C; Oliani C; Ponz de Leon M; Lanza G
    Clin Cancer Res; 2005 Dec; 11(23):8332-40. PubMed ID: 16322293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival.
    Watson MM; Kanani A; Lea D; Khajavi RB; Søreide JA; Kørner H; Hagland HR; Søreide K
    Ann Surg Oncol; 2020 Apr; 27(4):1058-1067. PubMed ID: 31686344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
    Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer.
    Lamberti C; Lundin S; Bogdanow M; Pagenstecher C; Friedrichs N; Büttner R; Sauerbruch T
    Int J Colorectal Dis; 2007 Feb; 22(2):145-52. PubMed ID: 16724208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection.
    Liang JT; Huang KC; Lai HS; Lee PH; Cheng YM; Hsu HC; Cheng AL; Hsu CH; Yeh KH; Wang SM; Tang C; Chang KJ
    Int J Cancer; 2002 Oct; 101(6):519-25. PubMed ID: 12237891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is elevated microsatellite alterations at selected tetranucleotide repeats (EMAST)-negative/MSI-high colorectal cancer a distinct subtype of the disease?
    Park Y; Kim DW; Hong YJ; Park KU; Nam SK; Na HY; Lee HS; Kim MH; Oh HK; Kang SB
    J Surg Oncol; 2020 Dec; 122(7):1462-1469. PubMed ID: 32779222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.